Spain has established itself as a leading hub for genomics research in Europe, driven by a robust network of academic institutions, research centers, and biotechnology companies. With national initiatives like the Spanish Genome Project and regional investments in precision medicine, the country is advancing genomic applications in areas such as cancer, rare diseases, and neurological disorders. Institutions like the Centre for Genomic Regulation (CRG) and the Spanish National Cancer Research Centre (CNIO) play a central role in these efforts.
Spain is also actively promoting open science and international collaboration, contributing to global databases and research consortia. Through public-private partnerships, Spain is investing in bioinformatics infrastructure and clinical translation, ensuring that discoveries reach patients in a timely and equitable way.
Specifically, Spain is working to:
With a strong commitment to research excellence and accessibility, Spain is shaping the future of genomics across Europe and beyond.
